Highline Wealth Partners’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10K Buy
106
+4
+4% +$381 ﹤0.01% 696
2026
Q2
$8.63K Buy
102
+15
+17% +$1.21K ﹤0.01% 671
2026
Q1
$6.15K Buy
87
+31
+55% +$2.32K ﹤0.01% 661
2025
Q4
$4.42K Sell
56
-11,348
-100% -$898K ﹤0.01% 591
2025
Q3
$939K Sell
11,404
-1
-0% -$79 0.25% 56
2025
Q2
$917K Buy
11,405
+36
+0.3% +$2.78K 0.27% 55
2025
Q1
$913K Buy
11,369
+2
+0% +$166 0.31% 58
2024
Q4
$931K Buy
11,367
+18
+0.2% +$1.5K 0.3% 56
2024
Q3
$936K Sell
11,349
-43
-0.4% -$3.21K 0.31% 57
2024
Q2
$800K Buy
11,392
+57
+0.5% +$4.07K 0.3% 58
2024
Q1
$840K Hold
11,335
– – 0.34% 59
2023
Q4
$750K Hold
11,335
– – 0.36% 63
2023
Q3
$713K Hold
11,335
– – 0.44% 53
2023
Q2
$641K Hold
11,335
– – 0.4% 60
2023
Q1
$657K Hold
11,335
– – 0.45% 55
2022
Q4
$820K Hold
11,335
– – 0.61% 49
2022
Q3
$689K Buy
+11,335
New +$724K 0.56% 46

Other funds holding MET

Highline Wealth Partners's MET Position: Q3 2026 in Review

Highline Wealth Partners increased its MetLife (MET) stake by 3.9% in Q3 2026, buying an estimated $381 and bringing the position to 106 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #696.

Highline Wealth Partners first reported a position in MET in Q3 2022 and has held it in 17 quarters since. The position peaked at $939K in Q3 2025. 1,309 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Highline Wealth Partners held 106 shares of MetLife worth $10K as of Q3 2026.
  • Highline Wealth Partners bought 4 MetLife shares in Q3 2026, an estimated $381.
  • MetLife made up ﹤0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #696 holding.
  • Highline Wealth Partners first reported a position in MetLife in Q3 2022 and has held it in 17 quarters since.
  • Highline Wealth Partners's MetLife position peaked at $939K in Q3 2025.
  • 1,309 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.